Literature DB >> 9987557

Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort.

B Langholz1, D Thomas, A Xiang, D Stram.   

Abstract

BACKGROUND: Latency effects are an important factor in assessing the public health implications of an occupational or environmental exposure. Usually, however, latency results as described in the literature are insufficient to answer public health related questions. Alternative approaches to the analysis of latency effects are warranted.
METHODS: A general statistical framework for modeling latency effects is described. We then propose bilinear and exponential decay latency models for analyzing latency effects as they have parameters that address questions of public health interest. Methods are described for fitting these models to cohort or case-control data; statistical inference is based on standard likelihood methods. APPLICATION: A latency analysis of radon exposure and lung cancer in the Colorado Plateau uranium miners cohort was performed. We first analyzed the entire cohort and found that the relative risk associated with exposure increases for about 8.5 years and thereafter decreases until it reaches background levels after about 34 years. The hypothesis that the relative risk remains at its peak level is strongly rejected (P < 0.001). Next, we investigated the variation in the latency effects over subsets of the cohort based on attained age, level and rate of exposure, and smoking. Age was the only factor for which effect modification was demonstrated (P = 0.014). We found that the decline in effect is much steeper at older ages (60+ years) than younger.
CONCLUSION: The proposed methods can provide much more information about the exposure-disease latency effects than those generally used.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987557     DOI: 10.1002/(sici)1097-0274(199903)35:3<246::aid-ajim4>3.0.co;2-6

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  30 in total

1.  Fitting the two-stage model of carcinogenesis to nested case-control data on the Colorado Plateau uranium miners: dependence on data assumptions.

Authors:  Richard G E Haylock; Colin R Muirhead
Journal:  Radiat Environ Biophys       Date:  2003-11-15       Impact factor: 1.925

2.  Lagging exposure information in cumulative exposure-response analyses.

Authors:  David B Richardson; Stephen R Cole; Haitao Chu; Bryan Langholz
Journal:  Am J Epidemiol       Date:  2011-11-01       Impact factor: 4.897

3.  Healthy worker survivor bias in the Colorado Plateau uranium miners cohort.

Authors:  Alexander P Keil; David B Richardson; Melissa A Troester
Journal:  Am J Epidemiol       Date:  2015-04-01       Impact factor: 4.897

4.  Age at exposure to ionising radiation and cancer mortality among Hanford workers: follow up through 1994.

Authors:  S Wing; D B Richardson
Journal:  Occup Environ Med       Date:  2005-07       Impact factor: 4.402

5.  Estimation of the relative excess risk due to interaction and associated confidence bounds.

Authors:  David B Richardson; Jay S Kaufman
Journal:  Am J Epidemiol       Date:  2009-02-11       Impact factor: 4.897

6.  Are nested case-control studies biased?

Authors:  Bryan Langholz; David Richardson
Journal:  Epidemiology       Date:  2009-05       Impact factor: 4.822

7.  Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Risk of Cancer in Adults With Congenital Heart Disease.

Authors:  Coraline Danieli; Sarah Cohen; Aihua Liu; Louise Pilote; Liming Guo; Marie-Eve Beauchamp; Ariane J Marelli; Michal Abrahamowicz
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

8.  Hierarchical latency models for dose-time-response associations.

Authors:  David B Richardson; Richard F MacLehose; Bryan Langholz; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2011-02-08       Impact factor: 4.897

9.  Quantifying risk over the life course - latency, age-related susceptibility, and other time-varying exposure metrics.

Authors:  Molin Wang; Xiaomei Liao; Francine Laden; Donna Spiegelman
Journal:  Stat Med       Date:  2016-01-10       Impact factor: 2.373

Review 10.  Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety.

Authors:  Simone P Pinheiro; Donna R Rivera; David J Graham; Andrew N Freedman; Jacqueline M Major; Lynne Penberthy; Mark Levenson; Marie C Bradley; Hui-Lee Wong; Rita Ouellet-Hellstrom
Journal:  Ann Epidemiol       Date:  2016-08-31       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.